WebDRNA Dicerna Pharmaceuticals Inc Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recom...
2024-12-25 Press Release Dicerna Announces Expiration ... - stockhouse
WebThe Schedule TO relates to the tender offer to acquire all of the outstanding Shares for $38.00 per Share (the “Offer Price”), to be paid to the seller in cash, without interest and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions set forth in the Offer to Purchase ... WebNov 18, 2024 · Novo Nordisk's juicy buyout offer values Dicerna Pharmaceuticals at $3.3 billion. At the moment, Dicerna's pipeline has a handful of midstage candidates and one in late-stage trials called nedosiran. chrome wiper arm covers
Novo Nordisk Announces Completion of Dicerna …
WebDec 25, 2024 · LEXINGTON, Mass., December 25, 2024--Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna WebThe tender offer described in this document has not yet commenced. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares of Dicerna, nor is it a substitute for any tender offer materials that Novo Nordisk or Dicerna will file with the SEC. WebDec 25, 2024 · December 25, 2024 - 8:00 am. LEXINGTON, Mass. Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, … chrome wire chafer stand kit